Petros Pharmaceuticals, Inc. (PTPI)
USD 0.05
(-3.36%)
USD 0.05
(-3.36%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.61 Million USD | 32.08% |
| 2022 | -15.84 Million USD | 12.2% |
| 2021 | -18.04 Million USD | -4.43% |
| 2020 | -17.28 Million USD | -2.45% |
| 2019 | -16.86 Million USD | -120.49% |
| 2018 | -7.65 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.92 Million USD | 22.04% |
| 2024 Q2 | -2.28 Million USD | 41.94% |
| 2023 Q2 | -2.46 Million USD | -88.1% |
| 2023 Q3 | -4.8 Million USD | -95.17% |
| 2023 FY | -10.76 Million USD | 32.08% |
| 2023 Q4 | -5.03 Million USD | -4.83% |
| 2023 Q1 | -1.3 Million USD | 68.07% |
| 2022 FY | -15.84 Million USD | 12.2% |
| 2022 Q4 | -4.1 Million USD | 70.0% |
| 2022 Q3 | -13.67 Million USD | -722.91% |
| 2022 Q2 | -1.66 Million USD | -245.27% |
| 2022 Q1 | -481.19 Thousand USD | 93.96% |
| 2021 FY | -18.04 Million USD | -4.43% |
| 2021 Q4 | -7.97 Million USD | -121.69% |
| 2021 Q3 | -3.59 Million USD | 15.98% |
| 2021 Q2 | -4.28 Million USD | -94.8% |
| 2021 Q1 | -2.19 Million USD | 49.11% |
| 2020 FY | -17.28 Million USD | -2.45% |
| 2020 Q4 | -4.31 Million USD | -84.81% |
| 2020 Q3 | -2.33 Million USD | 53.44% |
| 2020 Q2 | -5.01 Million USD | 10.54% |
| 2020 Q1 | -5.6 Million USD | 7.04% |
| 2019 Q1 | -1.86 Million USD | 0.0% |
| 2019 Q4 | -6.03 Million USD | -21.02% |
| 2019 FY | -16.86 Million USD | -120.49% |
| 2019 Q3 | -4.98 Million USD | -25.24% |
| 2019 Q2 | -3.98 Million USD | -113.28% |
| 2018 FY | -7.65 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 108.156% |
| Embecta Corp. | 221.5 Million USD | 106.148% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 128.991% |
| Dynavax Technologies Corporation | -37.02 Million USD | 63.224% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 91.246% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 115.532% |
| PainReform Ltd. | -9.58 Million USD | -42.084% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 9.831% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -184.567% |
| SCYNEXIS, Inc. | 72.66 Million USD | 118.739% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -441.399% |
| Cosmos Health Inc. | -21.83 Million USD | 37.624% |
| Journey Medical Corporation | -2.07 Million USD | -556.892% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -184.567% |
| Safety Shot Inc | -12.18 Million USD | -11.763% |
| Alpha Teknova, Inc. | -35.56 Million USD | 61.709% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 91.456% |
| Bright Green Corporation | -8.89 Million USD | -53.152% |
| Procaps Group, S.A. | 38.97 Million USD | 134.941% |
| Theratechnologies Inc. | -10.62 Million USD | -28.139% |
| Harrow Health, Inc. | 580 Thousand USD | 2447.821% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -189.67% |
| Biofrontera Inc. | -22.67 Million USD | 39.951% |
| DURECT Corporation | -36.88 Million USD | 63.081% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -158.443% |
| Cronos Group Inc. | -81.37 Million USD | 83.266% |
| OptiNose, Inc. | -22.74 Million USD | 40.138% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 106.514% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 65.22% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 207.801% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 208.721% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -214.031% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -119.252% |
| Radius Health, Inc. | -3.92 Million USD | -246.939% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -286.114% |
| ProPhase Labs, Inc. | -21.61 Million USD | 36.995% |
| Phibro Animal Health Corporation | 53.31 Million USD | 125.541% |
| Procaps Group S.A. | 52.32 Million USD | 126.025% |
| Alvotech | -354.86 Million USD | 96.163% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -59.772% |
| Viatris Inc. | 766.2 Million USD | 101.777% |
| Rockwell Medical, Inc. | -6.67 Million USD | -104.158% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -159.181% |
| SIGA Technologies, Inc. | 83.62 Million USD | 116.285% |
| Tilray Brands, Inc. | -174.74 Million USD | 92.207% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 245.937% |
| Shineco, Inc. | -17.06 Million USD | 20.207% |
| PetIQ, Inc. | 60.01 Million USD | 122.69% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -187.485% |
| Incannex Healthcare Limited | -30.04 Million USD | 54.671% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 105.427% |
| Alimera Sciences, Inc. | -1.47 Million USD | -825.722% |
| Silver Spike Investment Corp. | 7.34 Million USD | 285.52% |
| Assertio Holdings, Inc. | -243.53 Million USD | 94.408% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -131.101% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | 12.676% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 32.083% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 90.122% |
| Hempacco Co., Inc. | -8.81 Million USD | -54.527% |
| Talphera, Inc. | -16.88 Million USD | 19.371% |
| Alvotech | -354.86 Million USD | 96.163% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 125.475% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 103.734% |
| Currenc Group, Inc. | -6.64 Million USD | -104.902% |
| Kamada Ltd. | 10.06 Million USD | 235.308% |
| Indivior PLC | -4 Million USD | -240.434% |
| Evoke Pharma, Inc. | -7.43 Million USD | -83.253% |
| Flora Growth Corp. | -50.35 Million USD | 72.957% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 32.083% |
| Evolus, Inc. | -49.23 Million USD | 72.341% |
| HUTCHMED (China) Limited | 18.37 Million USD | 174.108% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 106.913% |
| Akanda Corp. | -10.05 Million USD | -35.478% |